Genetic Engineering & Biotechnology News – Sigmoid Pharma to Acquire Freund Pharmatec

Please link to the article below by which was posted in Feb 2016 by website.

Sigmoid Pharma is to acquire Freund Pharmatec for an undisclosed price. Freund is a drug delivery technology company and has committed to continue customer-funded R&D programs under Sigmoid management. Sigmoid develop drugs for immunological diseases and GI disorders and the acquisition of Freund will enable them to advance their lead programs through late-stage clinical development.

You can read the full article by clicking on the button below.

Share This Post!

If you are interested in becoming an Investor or seeking investment, then please contact us.